Track topics on Twitter Track topics that are important to you
The European Commission has launched a Phase II in-depth investigation into Bayer's planned $66 billion takeover of Monsanto, saying it has “preliminary concerns” that the deal, which would create the world's largest integrated pesticides and seeds company, “could reduce competition in a number of different markets resulting in higher prices, lower quality, less choice and less innovation."
Original Article: EU Starts In-Depth Probe of Bayer-MonsantoNEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...